NYSE: BNSBank Of Nova Scotia Stock
$47.11+0.22 (+0.47%)
Updated Apr 16, 2025
BNS Price
$47.11
Fair Value Price
N/A
Market Cap
$58.68B
52 Week Low
$43.68
52 Week High
$57.07
P/E
13.2x
P/B
0.98x
P/S
2.65x
PEG
0.44x
Dividend Yield
4.5%
Revenue
$24.37B
Earnings
$4.67B
Gross Margin
100%
Operating Margin
25.88%
Profit Margin
18%
Debt to Equity
15.95
Operating Cash Flow
$13B
Beta
0.74
Next Earnings
May 26, 2025
Ex-Dividend
Apr 1, 2025
Next Dividend
Apr 28, 2025
BNS Overview
Bank of Nova Scotia is a bank and financial services company. It is the third largest Canadian bank by deposits and market capitalization. It serves 25 million customers worldwide, offering personal and commercial banking, wealth management, and corporate and investment banking. Scotiabank was founded in 1832 and is headquartered in Halifax, Nova Scotia, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BNS's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diversified Bank
Industry Rating
F
BNS
Ranked#19 of 20
Ranked#19 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.56 | B | |
| $12.19 | C | |
| $13.11 | C |
Be the first to know about important BNS news, forecast changes, insider trades & much more!
BNS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BNS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BNS ($47.11) is trading below its intrinsic value of $55.47, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BNS is good value based on its earnings relative to its share price (13.2x), compared to the US market average (27.87x)
P/E vs Market Valuation
BNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BNS due diligence checks available for Premium users.
Valuation
BNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.2x
Industry
11.88x
Market
27.87x
BNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BNS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.98x
Industry
1.15x
BNS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BNS price to earnings growth (PEG)
For valuing profitable companies with growth potential
BNS is good value based... subscribe to Premium to read more.
PEG Value Valuation
BNS's financial health
Profit margin
Revenue
$6.5B
Net Income
$796.5M
Profit Margin
10.9%
BNS's Earnings (EBIT) of $6.31B... subscribe to Premium to read more.
Interest Coverage Financials
BNS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$999.4B
Liabilities
$939.4B
Debt to equity
15.95
BNS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.3B
Investing
-$2.9B
Financing
-$281.9M
BNS's operating cash flow ($12.74B)... subscribe to Premium to read more.
Debt Coverage Financials
BNS vs Diversified Bank Stocks
Bank Of Nova Scotia Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.